MedPath

Hyaluronic Matrix Efficacy for Maxillary Sinus Augmentation

Not Applicable
Completed
Conditions
Sinus; Dental
Interventions
Procedure: Maxillary Sinus Augmentation
Registration Number
NCT02692261
Lead Sponsor
Hacettepe University
Brief Summary

Sinus augmentation is a predictable method when alveolar bone height is not sufficient for dental implant placement in posterior maxillary alveolar region..The aim of this prospective, randomized, controlled clinical study is comparison of hyaluronic acid originated matrix and equine derived xenograft with only xenograft use in sinus augmentation by micro computed tomography and histomorphometry.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13
Inclusion Criteria
  • Systemically healthy patients
  • Requiring bilateral maxillary sinus augmentation (residual crest height ≤ 4 mm)
Exclusion Criteria
  • Advanced systemic diseases
  • Chronic medication use
  • Maxillary sinus disease
  • Current pregnancy
  • Lactation
  • Smoking habit

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Hyalossᵀᴹ matrixMaxillary Sinus AugmentationEach 0.5 cc Collagenated Heterolog Bone Graft, mixed with two bundles of Hyalossᵀᴹ matrix and a few drops of sterile saline solution used for maxillary sinus augmentation
Apatos alone xenograftMaxillary Sinus AugmentationEach sinus was filled with 1 gr xenograft (with or without Hyaluronic Acide) for maxillary sinus augmentation
Primary Outcome Measures
NameTimeMethod
Percentage of newly formed bone calculated from bone biopsises by Micro-CT and Histomorphometry4 months after surgery

Biological parameter obtained by analyzing bone biopsises

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath